Literature DB >> 7481202

Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP Working Party on Efficacy of Medicinal Products Note for Guidance III/3630/92-EN.

.   

Abstract

Mesh:

Year:  1995        PMID: 7481202     DOI: 10.1002/sim.4780141507

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  6 in total

1.  Quantitative image quality evaluation of MR images using perceptual difference models.

Authors:  Jun Miao; Donglai Huo; David L Wilson
Journal:  Med Phys       Date:  2008-06       Impact factor: 4.071

2.  Sample sizes for randomized trials measuring quality of life in cancer patients.

Authors:  S A Julious; S George; D Machin; R J Stephens
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

3.  Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels.

Authors:  Magdalena Żebrowska; Martin Posch; Dominic Magirr
Journal:  Stat Med       Date:  2015-12-23       Impact factor: 2.373

4.  Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials.

Authors:  Li-hong Huang; Jian-ling Bai; Hao Yu; Feng Chen
Journal:  J Biomed Res       Date:  2017-06-20

5.  Non-technical skills in surgery during the COVID-19 pandemic: An observational study.

Authors:  James C Etheridge; Rachel Moyal-Smith; Yves Sonnay; Mary E Brindle; Tze Tein Yong; Hiang Khoon Tan; Christine Lim; Joaquim M Havens
Journal:  Int J Surg       Date:  2022-01-04       Impact factor: 13.400

6.  Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.